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Introduction
Use of cigarettes and smokeless tobacco is a considerable
public health problem.1 In Turkey, a type of smokeless
tobacco called Maras powder (MP) is widely used in
the Southeastern region, especially in Kahramanmaras
and Gaziantep cities. MP is different from common cig-
arettes. It is used via the oral route, instead of smoked
in cigarettes.2 MP is often preferred while trying to quit
or reduce smoking.3 MP is obtained from a tobacco
plant species known as Nicotina rustica L. The sun-
dried leaves of the plant are powdered and mixed with
oak ash in 1:2 or 1:3 proportions (tobacco and ash,
respectively), and water is then sprinkled onto this mix-
ture for humidification (Figure 1). A small amount 
of this mixture (approximately 1 g) is applied between
the lower labial mucosa and gingiva for 4–5 minutes.
This region of the mouth has many capillary vessels,
so the nicotine is quickly absorbed into the circulation.2
Because MP has a higher nicotine content than ciga-
rettes, its harmful effects are also more pronounced.4
However, the public believes that this smokeless 
powder which they take orally is less harmful than cig-
arette smoking.3 Here, we present a case of paroxys-
mal atrial fibrillation (AF) that was suspected to be
caused by the use of MP, which has not previously
been noted in the literature.
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Figure 1. Maras powder for usage.
Case Report
A 46-year-old man was admitted to our emergency
department with angina pectoris and palpitation. The
patient had an attack of palpitation of the heart sud-
denly at about 7:00 a.m. He had been smoking ciga-
rettes for a long time and had begun using MP a
fortnight before. He had used MP three times a day
for the first 12 days. However, in the past 3 days, the
patient had used MP 8–10 times a day. He had come
to the hospital because of coughing a week before, and
it was found that his electrocardiogram (ECG) was in
normal sinus rhythm at that time. The patient had no
medical history of alcohol use, surgery, palpitation,
coronary arterial illness, hypertension or chronic bron-
chitis. Tachyarrhythmia was noted on physical examina-
tion. The Glasgow coma scale score of the patient was
E4M6V5. Arterial blood pressure was 120/80 mmHg.
The patient had normal complete blood count, blood
gases, blood electrolytes (Na, K, Mg, Ca) and serial
cardiac markers. Thyroxin and triiodothyronine con-
centrations and thyrotropin-releasing hormone stim-
ulation tests were normal. ECG showed AF with rapid
ventricular response, approximately 136 beats/min.
We administered intravenous amiodarone 150 mg
for medical cardioversion. AF was converted to sinus
rhythm after antiarrhythmic medication. During contin-
uous ECG monitoring in the emergency department,
no recurrence of arrhythmia was observed. Transtho-
racic echocardiography found no structural or func-
tional anomaly. Finally, no etiology other than MP
could explain this AF episode. We discharged the pa-
tient from the emergency department at his 24th hour
of admission with the suggestion that he quit MP
usage immediately.
At the 1-month follow-up, ECG showed normal
sinus rhythm, and during that time, he had no heart
palpitation or chest pain.
Discussion
MP is as harmful to health as cigarettes because of its
high nicotine content.4 The effect of nicotine on the
genesis of cardiac arrhythmias is well known.5 Animal
studies have demonstrated that nicotine delays ven-
tricular repolarization by blocking type-A potassium
channels in the heart. As a result of this, a number 
of arrhythmias occur.6 According to an experimental
study in dogs, no significant arrhythmias result with
doses of 2.5, 5.0 and 10.0 μg/kg of intravenous nico-
tine, but a dose of 50 μg/kg induced supraventricular
arrhythmias, atrioventricular junctional arrhythmias,
and ventricular arrhythmias.7 Stewart and Catterall8
reported paroxysmal AF occurring in a fit 35-year-old
man who had consumed large doses of nicotine chew-
ing gum over a prolonged period. Due to insufficient
technique, materials and equipment, we could not de-
termine serum nicotine concentration in our patient.
Mathew and Herity9 reported acute myocardial infarc-
tion developing within days of initiation of nicotine
replacement therapy. Smokeless tobacco may thus con-
ceivably trigger cardiac arrhythmias in susceptible indi-
viduals with an arrhythmogenic substrate. Risk for these
potential complications may be magnified in the con-
text of significant chewing-tobacco-induced increases
in blood pressure and heart rate.10 In the literature,
we came across numerous articles about the use of
nicotine-containing products leading to an interaction
with cardiovascular and various cardiac parameters.
However, there were no articles about MP use result-
ing in paroxysmal AF.3,9,10 Our case is noteworthy by
calling attention to the possibility that MP usage can
cause paroxysmal AF.
AF is the most common type of arrhythmia in
adults. Cardiac conditions associated with the devel-
opment of AF are hypertension, rheumatic mitral valve
disease, coronary artery disease, and congestive heart
failure. Noncardiac causes include hyperthyroidism,
hypoxic pulmonary conditions, surgery, and alcohol
intoxication.11 We did not find any cardiac or noncar-
diac organic pathologies that could have caused parox-
ysmal AF in this patient. The patient’s palpitations
developed in the 48 hours prior to his admission and
the patient had no history of AF. The AF was con-
verted to sinus rhythm after antiarrhythmic medica-
tion. After 1 month of follow-up, ECG showed normal
sinus rhythm.
In conclusion, the use of MP may lead to the
occurrence of paroxysmal AF.
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